Somayeh Samadzadeh Tarighat, PhD¹, Fei Fei^1*, Khuchtumur Bum-Erdene^2*, Helen Blanchard^2*, John Groffen^1* and Nora Heisterkamp, PhD^1*

¹Division of Hematology/Oncology and Bone Marrow Transplant, Children's Hospital Los Angeles, Los Angeles, CA
²Institute for Glycomics, Griffith University, Gold Coast Campus, Queensland, Australia

Alice Pecoraro^*, Antonio Troia^*, Angela Vitrano^*, Rosario Di Maggio^*, Massimiliano Sacco^*, Aurelio Maggio and Rosalba Di Marzo^*

Campus of Haematology Franco e Piera Cutino- A.O.O.R. “Villa Sofia-Cervello”, Palermo, Italy

Jiusheng Deng, PhD^1*, Dongkyoo Park, PhD^2*, Mengchang Wang^3*, Qiaoya Deng^2*, Shannon Matulis, PhD^4*, Lawrence H. Boise, PhD⁵ and Xingming Deng, MD, PhD^6*

¹Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA
²Emory Winship Cancer Institute, Atlanta
³The First Affiliated Hospital, Xi’An Jiaotong University, Xi'An, China
⁴Hematology and Medical Oncology, Emory University, Atlanta, GA
⁵Hematology & Medical Oncology, Emory University, Atlanta, GA
⁶Emory University Winship Cancer Institute, Atlanta, GA

Jing Lu, Ph.D.^1*, Yimin Qian, Ph.D.^1*, Kanak Raina, PhD^1*, Martha Altieri, MS^1*, Hanqing Dong, PhD^1*, Jing Wang, PhD^1*, Xin Chen, PhD^1*, Andrew Crew, PhD^1*, Kevin Coleman, PhD^1*, Craig Crews, PhD^2* and James Winkler, PhD¹

¹Arvinas, LLC, New Haven, CT
²Department of Molecular, Cellular, and Developmental Biology, Department of Chemistry, Department of Pharmacology, yale university, New Haven, CT

Jo Ishizawa, MD, PhD^1*, Kensuke Kojima, MD, PhD^1,2*, Dhruv Chachad, MS^3*, Peter Ruvolo, PhD³, Vivian Ruvolo, MS^4*, Rodrigo Omar Jacamo, PhD^3*, Gautam Borthakur, MD⁵, Hong Mu, MD, PhD^6*, Zhihong Zeng, MD⁴, Yoko Tabe, MD, PhD¹, Joshua Allen, Ph.D.^7*, Zhiqiang Wang, PhD^8*, Wencai Ma, PhD^9*, Hans Lee, MD^10*, Robert Z. Orlowski, Ph.D., M.D.⁹, Dos D. Sarbassov, PhD^11*, Sattva S. Neelapu, MD¹², Timothy J. McDonnell, MD, PhD¹³, Roberto N. Miranda, MD¹⁴, Michael Wang, MD¹², Hagop M Kantarjian, MD⁵, Marina Konopleva, MD, PhD¹, Richard Eric Davis, M.D.^8* and Michael Andreeff, M.D., Ph.D.¹

¹Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston
²Hematology, Respiratory Medicine and Oncology, Department of Medicine, Saga University, Saga, Japan
³Section of Molecular Hematology & Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Section of Molecular Hematology and Therapy, Leukemia Department, UT MD Anderson Cancer Center, Houston, TX
⁷Oncoceutics, Inc, Hummelstown, PA
⁸Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston
⁹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX
¹¹Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston
¹²Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
¹³Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston
¹⁴Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX

Stephen Joseph Shuttleworth, PhD

Karus Therapeutics, Abingdon, United Kingdom

Pritesh R. Patel, MB, ChB¹, Vitalyi Senyuk, PhD¹, Dolores Mahmud, PhD^1*, Annie L. Oh, MD¹ and Damiano Rondelli, MD²

¹Division of Hematology/Oncology, University of Illinois at Chicago, Chicago, IL
²Section of Hematology/Oncology, Dept. of Medicine, University of Illinois at Chicago, Chicago

David T Tran, PhD¹, Max J Petersen^1*, Charles O Noble, PhD^1*, Mark E Hayes, PhD^1*, Peter Working, PhD^1* and Francis C Szoka, PhD^1,2*

¹ZoneOne Pharma, Inc., San Francisco, CA
²Dept. of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA

Tomohiro Kozako, PhD¹, Makoto Yoshimitsu, MD, PhD², Naomichi Arima, MD, PhD³, Shuhei Soeda, PhD^1*, Shinya Hirata, MD, PhD^4*, Hiroaki Tanaka, PhD^5*, Shin-ichiro Honda, PhD^1* and Shinji Soeda, PhD^1*

¹Department of Biochemistry, Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, Japan
²Hem. and Immunology, Kagoshima University Hosp., Kagoshima, Japan
³Department of Hematology and Immunology, Kagoshima University Hospital, Kagoshima, Japan
⁴Department of Hematology, Kumamoto University Graduate School of Medicine, Kumamoto, Japan
⁵Faculty of Sports and Health Science, Fukuoka University, Fukuoka, Japan

Lata Chauhan, PhD^*, Emilie J Bergsma^* and Jatinder K Lamba, Ph.D

Department of Pharmacotherapy and Translational Research College of Pharmacy, University of Florida, Gainesville, FL